Summary: The Centers for Medicare & Medicaid Services modified its fecal occult blood test coverage policy, effective May 15, 2026. Here's what billing teams need to know before that date.
CMS fecal occult blood test coverage policy has been updated as of May 15, 2026. The Centers for Medicare & Medicaid Services governs screening colorectal cancer benefits under Medicare, and fecal occult blood testing sits at the center of that benefit. This policy document does not carry a specific policy code in CMS's standard numbering system. No specific CPT or HCPCS codes are listed in the source policy data — we'll address what that means for your billing team below.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Fecal Occult Blood Test |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | Medium |
| Specialties Affected | Gastroenterology, Primary Care, Internal Medicine, Preventive Medicine, Lab/Pathology billing |
| Key Action | Review your fecal occult blood test billing workflows and confirm your documentation meets updated medical necessity criteria before May 15, 2026 |
CMS Fecal Occult Blood Test Coverage Criteria and Medical Necessity Requirements 2026
Medicare has covered fecal occult blood testing as a colorectal cancer screening benefit for decades. The benefit sits under Medicare Part B and applies to eligible beneficiaries at defined screening intervals. The modification effective May 15, 2026 signals that CMS revisited the criteria, documentation expectations, or benefit structure — even if the source data does not spell out every line of what changed.
What hasn't changed: fecal occult blood testing is a covered preventive screening benefit under Medicare when it meets medical necessity and frequency criteria. CMS has historically covered this test annually for beneficiaries age 50 and older. That baseline coverage policy remains intact.
The real issue here is documentation. CMS modifications to preventive screening policies almost always tighten what you need on file to survive a post-payment audit. If your practice relies on fecal occult blood test billing as part of your preventive care volume, your medical records need to show that the patient met the age threshold, the frequency limit since the last test, and the ordering provider's rationale.
Prior authorization is not typically required for fecal occult blood testing under Medicare. That's consistent with the benefit's preventive status — Medicare Part B preventive services don't generally require prior auth. But absence of a prior authorization requirement doesn't mean absence of scrutiny. Medical necessity documentation still drives your claim's defensibility.
If your Medicare Administrative Contractor has issued a local coverage determination on colorectal cancer screening or fecal occult blood testing, check that LCD against this updated CMS policy. MACs can be more restrictive than national policy. This update may prompt MAC-level revisions as well, so watch for LCD activity from your regional contractor after May 15, 2026.
CMS Fecal Occult Blood Test Exclusions and Non-Covered Indications
The source policy data does not list specific exclusions. Based on longstanding CMS coverage policy for this benefit, the following situations have historically triggered claim denial or non-coverage:
| # | Excluded Procedure |
|---|---|
| 1 | Testing performed more frequently than the covered interval (annually for guaiac-based tests, with different intervals for newer stool DNA and immunoassay methods) |
| 2 | Testing ordered for diagnostic purposes rather than screening — once a patient has symptoms, the claim shifts from preventive to diagnostic, and different rules apply |
| 3 | Testing billed under the wrong benefit category, particularly when a diagnostic workup is underway |
This is worth flagging for your billing team. The screening versus diagnostic distinction is where most fecal occult blood test billing errors occur. A patient who reports rectal bleeding or a change in bowel habits is no longer a screening candidate. Billing the claim as preventive screening when the encounter is clearly diagnostic will get you a claim denial and potential audit exposure.
If your team isn't already flagging encounters where symptoms are documented alongside a fecal occult blood test order, build that checkpoint into your charge capture workflow now — before May 15, 2026.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Annual colorectal cancer screening, asymptomatic beneficiary age 50+ | Covered | Not listed in source policy data | Confirm frequency and age criteria per updated policy |
| Diagnostic workup for GI symptoms (bleeding, change in bowel habits) | Not Covered as screening | Not listed in source policy data | Bill as diagnostic — different coverage rules apply |
| Testing performed more frequently than covered interval | Not Covered | Not listed in source policy data | Claim denial risk; confirm date of last test before billing |
| Fecal immunochemical test (FIT) or stool DNA test | Coverage varies by method | Not listed in source policy data | Each test type may carry different frequency and coverage rules under CMS |
Note: The source policy document for this modification does not list specific CPT or HCPCS codes. See the Affected Codes section for what this means for your team.
CMS Fecal Occult Blood Test Billing Guidelines and Action Items 2026
The policy data for this modification does not include line-by-line criteria or a detailed summary of what specifically changed. That matters. When CMS issues a modification without a published summary in the payer policy record, your job is to pull the full policy document and compare it to the prior version yourself — or use a tool that does the version diff for you.
Here's what your team should do before May 15, 2026:
| # | Action Item |
|---|---|
| 1 | Pull the full CMS policy document. Go to the source at CMS.gov or your Medicare Administrative Contractor's website. Read the updated policy against the prior version. You're looking for changes to frequency limits, eligible test types, age criteria, or documentation requirements. |
| 2 | Audit your charge capture for fecal occult blood test billing. Make sure your team is using the correct procedure codes for the specific test type being performed. Guaiac-based tests, fecal immunochemical tests, and stool DNA tests each have distinct HCPCS codes — and CMS treats them differently. Since the source policy does not list specific codes, confirm which codes apply to your test menu directly from the current CMS fee schedule. |
| 3 | Confirm the screening versus diagnostic split in your workflow. Any patient with documented GI symptoms at the time of ordering should have that encounter flagged for diagnostic billing — not preventive. Build this into your intake and charge capture process. |
| 4 | Check your MAC's local coverage determination. Your regional Medicare Administrative Contractor may issue an updated LCD in response to this national policy modification. Sign up for LCD update alerts from your MAC if you haven't already. |
| 5 | Review your remittance advice for recent claim denials on this service. If you're already seeing denials on fecal occult blood test claims, the modified coverage policy effective May 15, 2026 may clarify the denial reason — or create new ones. Match your denial codes to the updated criteria. |
| 6 | Talk to your compliance officer before the effective date. If your practice has significant fecal occult blood test billing volume, or if you've had audit exposure on colorectal cancer screening claims in the past, loop in your compliance officer now. Don't wait until May 15 to figure out whether your documentation meets the updated standard. |
Reimbursement for fecal occult blood testing is modest per claim. But volume matters, and so does audit risk. A pattern of incorrect billing on preventive screening claims — even low-dollar ones — draws Recovery Audit Contractor attention.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Fecal Occult Blood Test Under This CMS Policy
Important note: The source policy document for this CMS modification does not list specific CPT, HCPCS, or ICD-10 codes. We do not publish codes we cannot verify directly from the policy data. Publishing invented or assumed codes would create claim denial risk for your team — that's not a trade-off worth making.
What to Do Instead
Verify the applicable codes directly from these authoritative sources before your next billing cycle:
- CMS Medicare Claims Processing Manual, Chapter 18 (Preventive and Screening Services) — this is where Medicare's colorectal cancer screening benefit is defined, including covered test types and HCPCS codes
- Your MAC's fee schedule and LCD — search for "colorectal cancer screening" or "fecal occult blood" in your contractor's coverage database
- The CMS Physician Fee Schedule lookup tool — confirm current reimbursement rates by code and geographic area
Known Code Categories to Verify
Based on standard CMS billing guidelines for colorectal cancer screening, your billing team should confirm current coding for:
- Guaiac-based fecal occult blood tests (gFOBT)
- Fecal immunochemical tests (FIT)
- Stool DNA combination tests (when applicable under Medicare benefit rules)
- Relevant ICD-10-CM diagnosis codes for colorectal cancer screening (Z-codes) versus diagnostic encounters
Do not assume the codes your team has used historically are unchanged. Part of what makes this modification worth flagging is that code-level changes often accompany benefit modifications — and the only way to confirm is to check the full policy document and current fee schedule.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.